Mandate

Vinge advises Active Biotech in its new issue

April 06, 2009

Vinge has advised Active Biotech in its new issue of shares subject to pre-emption rights for the existing shareholders. Under the new issue, which is underwritten in its entirety by the principal shareholders MGA Holding and Nordstjernan, Active Biotech receives approximately SEK 256 million.

Vinge’s team was led by Erik Sjöman who was assisted by, among others, associates Christian Lindhé, Karolina Tjärnberg Jansson and Maria Doeser (tax law advice).

Related

Vinge advises KEYTO Group in connection with the acqusition of Säkra Larm

KEYTO Group continues to broaden its home services offering as Säkra Larm joins the Group, establishing home security as a new business vertical within KEYTO. The addition marks another important step in KEYTO's ambition to become the leading one-stop destination for services connected to the home.
September 24, 2026

Vinge has advised Ingrid Capacity in connection with the formation of a strategic partnership with Mirova for a strategic partnership for a large-scale BESS portfolio in the Nordics

Ingrid Capacity and Mirova, an affiliate of Natixis Investment Managers dedicated to sustainable investment, announce a cross-border partnership of two BESS projects totalling 145 MW/290 MWh in Sweden and Finland. Vinge has advised Ingrid Capacity in connection with the formation of the partnership.
September 24, 2026

Vinge advises the financing banks in connection with Verdane and Telenor’s partnership in Telenor Connexion

Vinge has advised a syndicate of Nordic and Northern European banks connection with the financing of Verdane and Telenor’s new partnership relating to Telenor Connexion. Under the partnership, Verdane and Telenor will jointly invest in Telenor Connexion, a leading provider of IoT solutions. The transaction was completed on 10 September 2026 and values Telenor Connexion at SEK 7.5 billion.
September 23, 2026